Roche obesity data read-throughs ‘may be a bit premature,’ says RBC Capital
PremiumThe FlyRoche obesity data read-throughs ‘may be a bit premature,’ says RBC Capital
9d ago
Gilead chief medical officer Merdad Parsey to depart early 2025
PremiumThe Fly
Gilead chief medical officer Merdad Parsey to depart early 2025
10d ago
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
14d ago
Gilead upgraded to Outperform from Market Perform at Raymond James
PremiumThe FlyGilead upgraded to Outperform from Market Perform at Raymond James
19d ago
Arcus Biosciences drops 6% after Roche lung cancer failure
PremiumThe Fly
Arcus Biosciences drops 6% after Roche lung cancer failure
22d ago
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
PremiumThe Fly
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
22d ago
Early notable gainers among liquid option names on June 21st
PremiumThe FlyEarly notable gainers among liquid option names on June 21st
1M ago
Unusually active option classes on open June 21st
PremiumThe Fly
Unusually active option classes on open June 21st
1M ago
Gilead Sciences Stock (GILD) Gained on Promising Trial Results
PremiumMarket News
Gilead Sciences Stock (GILD) Gained on Promising Trial Results
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100